心力衰竭患者恶性肿瘤发病率的时间趋势:丹麦全国性研究
该研究利用丹麦全国登记数据,纳入1997至2016年间诊断心衰后存活1年且无癌症的103 711例30-80岁患者,计算诊断后每年5年癌症发病率。
要点
- 心衰诊断后1-6年内癌症发病率在1997-2016年间保持稳定。
- 心衰患者长期生存率显著提高,5年累积生存率从55.9%升至74.3%。
- 癌症5年绝对风险稳定在9.0%,未随日历年份变化。
核心结论
- 1997-2016年间,心衰诊断后1-6年内癌症发病率保持稳定,但心衰诊断后长期生存率显著增加。
研究设计与样本
- 基于丹麦全国登记数据的回顾性队列研究,纳入1997年1月1日至2016年12月31日间诊断心衰后存活1年、无癌症且年龄30-80岁的103 711例患者。
主要发现
- 1997年与2016年5年癌症发病率分别为20.9与20.2/1000人年。
- 5年癌症绝对风险从1997-2001年的9.0%至2012-2016年的9.0%保持不变。
- 心衰5年累积生存率从1997-2001年的55.9%增至2012-2016年的74.3%。
临床怎么用
- 心衰患者癌症风险未随时间增加,但生存改善提示需关注长期非心血管共病管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Cancer and heart failure (HF) share risk factors, pathophysiological mechanisms, and possibly genetics. Improved HF survival may increase the risk of cancer due to a competing risk. Whether the incidence of cancer has increased over time in patients with HF as survival has improved is unclear. Therefore, temporal trends of new onset cancer in HF patients between 1997 and 2016 were investigated. METHODS AND RESULTS: Using Danish nationwide registers, 103 711 individuals alive, free of cancer, and aged 30-80 years 1 year after HF diagnosis (index date) were included between 1 January 1997 and 31 December 2016. A five-year incidence rate of cancer for each year after index date was calculated. The median age and proportion of women at the index date decreased with advancing calendar time [1997-2001: 70.3 interquartile range (Q1-Q3 62.5-75.7), 60.9% men; 2012-16: 67.6 (59.2-73.8), 67.5% men]. The five-year incidence rate of cancer was 20.9 and 20.2 per 1,000 person-years in 1997 and 2016, respectively. In a multivariable Cox regression model, the hazard rates between index years 1997 (reference) and 2016 were not significantly different [hazard ratio 1.09 (0.97-1.23)]. The five-year absolute risk of cancer did not change with advancing calendar year, going from 9.0% (1997-2001) to 9.0% (2012-16). Five-year cumulative incidence of survival for HF patients increased with advancing calendar year, going from 55.9% (1997-2001) to 74.3% (2012-2016). CONCLUSION: Although cancer rates during 1997-2016 have remained stable within 1-6 years after the HF diagnosis, long-term survival following a HF diagnosis has increased significantly.
引用
- Bruhn, Malmborg, Garred, et al. Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study. Eur Heart J. 2023. PMID: 36691953. doi:10.1093/eurheartj/ehac797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。